Adaptive Biotechnologies Corporation (ADPT) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGS. Market cap 4.16B USD. 52-week range 12.00 to 30.74 USD. Data as of 2026-10-09.
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a ...